Tumour targeting and therapy experiments using a chemically-modified human antibody fragment directed against the ED-B domain of fibronectin, a marker of angiogenesis
Closed access
Author
Date
2000Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-004027258Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH ZürichSubject
ANGIOGENESE + VASKULOGENESE (ANATOMIE, PHYSIOLOGIE); TUMORMARKER (MEDIZINISCHE DIAGNOSTIK); FIBRONEKTIN (GLYKOPROTEINE); ANTIKÖRPERTECHNIKEN (IMMUNOLOGISCHE TECHNIKEN); KREBSTHERAPIE + TUMORTHERAPIE (MEDIZIN); ANGIOGENESIS + NEOVASCULARIZATION (ANATOMIE, PHYSIOLOGY); TUMOUR MARKERS (MEDICAL DIAGNOSTICS); FIBRONECTIN (GLYCOPROTEINS); ANTIBODY TECHNIQUES (IMMUNOLOGICAL TECHNIQUES); CANCER TREATMENT + TUMOUR TREATMENT (MEDICINE)Organisational unit
03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
Notes
Diss. Naturwissenschaften ETH Zürich, Nr. 13680, 2000.More
Show all metadata
ETH Bibliography
yes
Altmetrics